Israel Pharmaceuticals & Healthcare Report Q2 2018
Israel will continue to present an attractive opportunity for the sale of patented high-value medicines, with the expansionof the country's health basket set to include additional innovative treatments in 2018. It was announced in December 2017 thatIsrael's basket of health services will be expanded by ILS430mn (USD137mn) in 2018, with over 106 new drugs being added to thegovernment-subsidised list. This corresponds to a similar medicine budget as allocated in 2017 and highlights the Israeligovernment's ongoing commitment to improving patients' access to more 'lifesaving treatments', particularly focusing on theaffordability of diabetes, oncology and rare disease treatments.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook